Annual Accounts Payable
$1.38 M
-$261.00 K-15.91%
December 31, 2023
Summary
- As of February 7, 2025, ABOS annual accounts payable is $1.38 million, with the most recent change of -$261.00 thousand (-15.91%) on December 31, 2023.
- During the last 3 years, ABOS annual accounts payable has risen by +$848.00 thousand (+159.70%).
- ABOS annual accounts payable is now -15.91% below its all-time high of $1.64 million, reached on December 31, 2022.
Performance
ABOS Accounts Payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Accounts Payable
$2.34 M
-$1.87 M-44.38%
September 30, 2024
Summary
- As of February 7, 2025, ABOS quarterly accounts payable is $2.34 million, with the most recent change of -$1.87 million (-44.38%) on September 30, 2024.
- Over the past year, ABOS quarterly accounts payable has increased by +$980.00 thousand (+71.95%).
- ABOS quarterly accounts payable is now -44.38% below its all-time high of $4.21 million, reached on June 30, 2024.
Performance
ABOS Quarterly Accounts Payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Accounts Payable Formula
Accounts Payable = Beginning Accounts Payable + Purchases on Credit − Payments to Suppliers
ABOS Accounts Payable Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -15.9% | +72.0% |
| 3 y3 years | +159.7% | +15.6% |
| 5 y5 years | +518.4% | +15.6% |
ABOS Accounts Payable Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -15.9% | +26.8% | -44.4% | +207.3% |
| 5 y | 5-year | -15.9% | +518.4% | -44.4% | +513.1% |
| alltime | all time | -15.9% | +518.4% | -44.4% | +513.1% |
Acumen Pharmaceuticals Accounts Payable History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $2.34 M(-44.4%) |
| Jun 2024 | - | $4.21 M(+36.8%) |
| Mar 2024 | - | $3.08 M(+123.3%) |
| Dec 2023 | $1.38 M(-15.9%) | $1.38 M(+1.2%) |
| Sep 2023 | - | $1.36 M(-32.8%) |
| Jun 2023 | - | $2.03 M(+165.9%) |
| Mar 2023 | - | $762.00 K(-53.5%) |
| Dec 2022 | $1.64 M | $1.64 M(-21.3%) |
| Sep 2022 | - | $2.08 M(+21.9%) |
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2022 | - | $1.71 M(+40.3%) |
| Mar 2022 | - | $1.22 M(+12.0%) |
| Dec 2021 | $1.09 M(+104.9%) | $1.09 M(+184.8%) |
| Sep 2021 | - | $382.00 K(-86.9%) |
| Jun 2021 | - | $2.91 M(+216.7%) |
| Mar 2021 | - | $918.00 K(+72.9%) |
| Dec 2020 | $531.00 K(+138.1%) | - |
| Dec 2020 | - | $531.00 K |
| Dec 2019 | $223.00 K | - |
FAQ
- What is Acumen Pharmaceuticals annual accounts payable?
- What is the all time high annual accounts payable for Acumen Pharmaceuticals?
- What is Acumen Pharmaceuticals annual accounts payable year-on-year change?
- What is Acumen Pharmaceuticals quarterly accounts payable?
- What is the all time high quarterly accounts payable for Acumen Pharmaceuticals?
- What is Acumen Pharmaceuticals quarterly accounts payable year-on-year change?
What is Acumen Pharmaceuticals annual accounts payable?
The current annual accounts payable of ABOS is $1.38 M
What is the all time high annual accounts payable for Acumen Pharmaceuticals?
Acumen Pharmaceuticals all-time high annual accounts payable is $1.64 M
What is Acumen Pharmaceuticals annual accounts payable year-on-year change?
Over the past year, ABOS annual accounts payable has changed by -$261.00 K (-15.91%)
What is Acumen Pharmaceuticals quarterly accounts payable?
The current quarterly accounts payable of ABOS is $2.34 M
What is the all time high quarterly accounts payable for Acumen Pharmaceuticals?
Acumen Pharmaceuticals all-time high quarterly accounts payable is $4.21 M
What is Acumen Pharmaceuticals quarterly accounts payable year-on-year change?
Over the past year, ABOS quarterly accounts payable has changed by +$980.00 K (+71.95%)